First Accredited CME Course on BSGI - the Molecular Breast Imaging Exam, Now Available to All Physicians
Posted on: Thursday, 25 September 2008, 12:00 CDT
NEWPORT NEWS, Va., Sept. 25 /PRNewswire/ -- The Institute for Advanced Medical Education in partnership with WebMedEd and Applied Radiology now offers an online CME course on Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging exam. The course is designed to educate physicians on the utility of BSGI as a critical adjunct procedure to mammography, ultrasound and MRI to help diagnose early stage breast cancers, particularly types that can be difficult to detect, such as DCIS and lobular carcinoma.
The program is accredited for Two (2) AMA/PRA CME Credits(TM) and is divided into a five-module presentation. Dr. Margaret Bertrand with Solis Bertrand Breast Center in Greensboro, NC presents an "Interpretation and Comparison to Other Modalities" and Dr. Ward Parsons with The Rose Breast Center in Houston, TX presents "A Molecular Imaging Complement To Breast Diagnostics: Technology and Clinical Indications." The online course also includes several case presentations from each physician, as well as an interview session covering some of the most talked about topics in molecular breast imaging.
Additionally, two live BSGI programs have been delivered thus far, one in Boston on May 17 and the other, most recently in Chicago this past weekend. An attendee at the Chicago meeting and a user of the technology, Dr. Nathalie Johnson, breast surgeon and Director of Breast Health Care services at Legacy Health systems, Portland Oregon, said that "The new BSGI CME course is spectacular. I gained a lot of insight by sharing with other physician's their breast imaging experiences and reviewing interesting cases. It is a comprehensive overview of the technology, biology and clinical utility of molecular breast Imaging."
The Two (2) Credit AMA/PRA Category 1 CME Credit(TM) online course is offered through August 2010 and the program is made possible by an unrestricted educational grant from Dilon Technologies, maker of molecular imaging products and related services. For more information on this course or to register for the BSGI CME program, please visit http://www.appliedradiology.org/BSGI.
About Dilon Technologies
Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York, George Washington University Medical Center, Washington, D.C. and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com/.
About IAME
The Institute for Advanced Medical Education was established in 1992 and provides continuing medical education to physicians, nurses and allied health professionals in the form of live events, multimedia and print programs. IAME is the nation's leading provider of CME in diagnostic imaging in addition to offering innovative programs in neurology, gastroenterology, women's health and cardiovascular medicine. IAME is accredited by the Accreditation Council for Continuing Medical Education (ACCME).
Dilon Technologies
CONTACT: Nancy F. Morter of Dilon Technologies, Inc., +1-757-269-4910,ext. 302, Cell, +1-757-589-3914, nfmorter@dilon.com
Web site: http://www.dilon.com/
Source: PRNewswire
Related Articles
- Dilon Technologies Leads Molecular Breast Imaging Expansion
- New Data on Breast Imaging Using Cardiolite(R) to Be Presented at ASCO Breast Cancer Symposium
- Solis Women's Health Brings Molecular Breast Imaging to Dallas-Fort Worth Metroplex
- Bexion Partners With Molecular Targeting Technologies on Novel Cancer Imaging Agent
- Imaging Diagnostic Systems Laser Breast Imaging Technology Presented at China's Leading Breast Disease Conference
- Houston Technology Center Announces $2 Million Award to PLx Pharma Inc., $794,520 Award to Molecular LogiX Inc. By the Texas Emerging Technology Fund
- Molecular Breast Imaging Finds Tiny Tumors
- Maimonides Medical Center Partners With the Health Technology Center for Access to Industry-Leading Healthcare Technology Forecasts and Business Solutions
- Elizabeth Jekot, M.D. Breast Imaging Center Offers Aurora Breast MRI to the Women of Richardson, Texas
User Comments (0)

RSS Feeds